This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Maximize your weekends with these quick money-making ideas. Discover ways to earn extra cash without a long-term commitment.
19,179 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
SBI Holdings moves to launch Japan's first spot XRP ETF, prioritizing XRP over Ethereum due to regulatory fit and a d...
Oracle is leaning into AI infrastructure with its database expertise, cloud platform, and data-center plans. This art...
Investors are reallocating spending toward resale, repair, and value brands. Six ETFs are positioned to ride the circ...
On March 19, 2026, Suze Orman addressed a listener’s question about inherited IRAs, clarifying that non-spouse benefi...
Lionsgate faces a shifting media world where film, TV, and streaming collide. This guide breaks down the 2026 earning...
Two popular dividend ETFs take different paths: one prioritizes growing income with minimal fees, the other aims for ...
Regulators are leaning into nonprofit oversight, boosting enforcement actions even as verified cases of nonprofit fra...
When a major hedge fund trims a stake in a diversified telecom, it sends a message to the market. This article breaks...
Billionaire Mark Cuban says crypto has disappointed him, selling most of his Bitcoin, while Ethereum holds some appea...
Nokia is quietly positioning itself as a top infrastructure play in AI networking, challenging Cisco's dominance with...
SoFi CEO Anthony Noto quietly bought the dip in SOFI stock across four trades this spring. This article breaks down t...